A clinical trial evaluating an investigational medication for prevention of migraine headaches.
Do you suffer from migraines?
A clinical research study is being conducted to learn if an investigational drug may help prevent migraines.
A migraine is a strong headache that often comes with nausea, vomiting, and sensitivity to light. It can last hours or days. Migraines are different in everyone. A migraine headache often begins as a dull ache and grows into throbbing pain. It usually gets worse during physical activity. The pain can move from one side of your head to the other, can be in the front of your head, or can feel like it’s affecting your entire head. About 80% of people have nausea along with a headache, and about half vomit. You may also be pale and clammy or feel faint. Most migraine headaches last about 4 hours, but severe ones can go for more than 3 days. It’s common to get two to four headaches per month. Some people may get migraine headaches every few days, while others get them once or twice a year. In many people, they happen in stages. The first stage being prodrome which onset hours or days before a headache, about 60% of people who have migraines notice symptoms.
IPS Research is seeking participants who experience prodrome symptoms prior to onset of headache pain for a clinical trial of an investigational medication to help prevent migraine headaches.
Qualified Participants must be:
- Between the ages of 18 and 80
- Experiencing prodrome symptoms prior to migraine pain such as:
- Being sensitive to light, sound, or smell
- Food cravings or lack of appetite
- Mood changes
- Severe thirst
- Constipation or diarrhea
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel